Performance of pre-sprouted sugarcane seedlings in response to the application of humic acid and plant growth-promoting bacteria

Sugarcane cultivation using pre-sprouted seedlings has decreased the number of stalks used per hectare, increased the multiplication rate, improved seedling health, and increased planting uniformity. However, because this system has been only recently proposed, the number of studies evaluating this new technology is still scarce, particularly those examining the effect of the application of growth-promoting substances on seedling characteristics during the production phase. Here, we hypothesized that it is possible to combine the plant growth-promoting activity of humic acid (HA) with the inoculation of selected strains of plant growth-promoting bacteria (PGPB) to improve the yield of sugarcane seedlings compared with the individual application of these two techniques. The potential of the combined use of HA and PGPB as agricultural inputs was evaluated by conducting an experiment with sugarcane micro cuttings in a greenhouse. Treatments included control, PGPB, HA, and PGPB with HA. At the end of the experiment (60 d after planting), the plants were subjected to biometric evaluation. The results indicated that it was possible to combine HA with selected strains of PGPB (Burkholderia sp.) to improve the yield of seedlings compared with individual HA and PGPB treatments. HA, PGPB, and HA + PGPB increased the total dry matter compared with the control by 23%, 25%, and 36%, respectively. Therefore, the use of HA-based plant regulators in combination with PGPB was more effective than the isolated use of these inputs for the treatment of micro cuttings and improvement of sugarcane seedling yield

Initial performance of maize in response to humic acids and plant growth-promoting bacteria

ABSTRACT Seed treatment with inoculants based on plant growth-promoting bacteria (PGPB) or the application of humic acids (HA) may increase the productivity of plants of agricultural interest. The hypothesis of this work is that it is possible to combine the effect of plant growth promoting characteristic of HA with the inoculation of PGPB selected strains in the treatment of maize seeds. Thus, providing superior responses than in single applications of both in the initial maize development. To meet this purpose, we conducted isolated application of HA or PGPB inoculation of Burkholderia gladioli and Rhizobium cellulosilyticum, and the combined application of PGPB and HA for treatment of maize seeds. At the end of the experiment (45 days after germination), the plants were evaluated biometrically, nutritionally and a bacteria count was performed in plants using the Most Probable Number technique. The results showed that it is possible to combine the effects of HA with the inoculation of selected strains of PGPB, obtaining superior responses to the isolated application of both. Thus, the use of HA-based bio-stimulants in combination with PGPB is positive and complementary compared to inputs generally used in the treatment of maize seeds

Initial performance of maize in response to humic acids and plant growth-promoting bacteria

<div><p>ABSTRACT Seed treatment with inoculants based on plant growth-promoting bacteria (PGPB) or the application of humic acids (HA) may increase the productivity of plants of agricultural interest. The hypothesis of this work is that it is possible to combine the effect of plant growth promoting characteristic of HA with the inoculation of PGPB selected strains in the treatment of maize seeds. Thus, providing superior responses than in single applications of both in the initial maize development. To meet this purpose, we conducted isolated application of HA or PGPB inoculation of Burkholderia gladioli and Rhizobium cellulosilyticum, and the combined application of PGPB and HA for treatment of maize seeds. At the end of the experiment (45 days after germination), the plants were evaluated biometrically, nutritionally and a bacteria count was performed in plants using the Most Probable Number technique. The results showed that it is possible to combine the effects of HA with the inoculation of selected strains of PGPB, obtaining superior responses to the isolated application of both. Thus, the use of HA-based bio-stimulants in combination with PGPB is positive and complementary compared to inputs generally used in the treatment of maize seeds.</p></div

Impact of the COVID-19 pandemic on patients with paediatric cancer in low-income, middle-income and high-income countries: a multicentre, international, observational cohort study

OBJECTIVES: Paediatric cancer is a leading cause of death for children. Children in low-income and middle-income countries (LMICs) were four times more likely to die than children in high-income countries (HICs). This study aimed to test the hypothesis that the COVID-19 pandemic had affected the delivery of healthcare services worldwide, and exacerbated the disparity in paediatric cancer outcomes between LMICs and HICs. DESIGN: A multicentre, international, collaborative cohort study. SETTING: 91 hospitals and cancer centres in 39 countries providing cancer treatment to paediatric patients between March and December 2020. PARTICIPANTS: Patients were included if they were under the age of 18 years, and newly diagnosed with or undergoing active cancer treatment for Acute lymphoblastic leukaemia, non-Hodgkin's lymphoma, Hodgkin lymphoma, Wilms' tumour, sarcoma, retinoblastoma, gliomas, medulloblastomas or neuroblastomas, in keeping with the WHO Global Initiative for Childhood Cancer. MAIN OUTCOME MEASURE: All-cause mortality at 30 days and 90 days. RESULTS: 1660 patients were recruited. 219 children had changes to their treatment due to the pandemic. Patients in LMICs were primarily affected (n=182/219, 83.1%). Relative to patients with paediatric cancer in HICs, patients with paediatric cancer in LMICs had 12.1 (95% CI 2.93 to 50.3) and 7.9 (95% CI 3.2 to 19.7) times the odds of death at 30 days and 90 days, respectively, after presentation during the COVID-19 pandemic (p<0.001). After adjusting for confounders, patients with paediatric cancer in LMICs had 15.6 (95% CI 3.7 to 65.8) times the odds of death at 30 days (p<0.001). CONCLUSIONS: The COVID-19 pandemic has affected paediatric oncology service provision. It has disproportionately affected patients in LMICs, highlighting and compounding existing disparities in healthcare systems globally that need addressing urgently. However, many patients with paediatric cancer continued to receive their normal standard of care. This speaks to the adaptability and resilience of healthcare systems and healthcare workers globally

Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic

Childhood cancer is a leading cause of death. It is unclear whether the COVID-19 pandemic has impacted childhood cancer mortality. In this study, we aimed to establish all-cause mortality rates for childhood cancers during the COVID-19 pandemic and determine the factors associated with mortality

Global economic burden of unmet surgical need for appendicitis

Background There is a substantial gap in provision of adequate surgical care in many low- and middle-income countries. This study aimed to identify the economic burden of unmet surgical need for the common condition of appendicitis. Methods Data on the incidence of appendicitis from 170 countries and two different approaches were used to estimate numbers of patients who do not receive surgery: as a fixed proportion of the total unmet surgical need per country (approach 1); and based on country income status (approach 2). Indirect costs with current levels of access and local quality, and those if quality were at the standards of high-income countries, were estimated. A human capital approach was applied, focusing on the economic burden resulting from premature death and absenteeism. Results Excess mortality was 4185 per 100 000 cases of appendicitis using approach 1 and 3448 per 100 000 using approach 2. The economic burden of continuing current levels of access and local quality was US $92 492 million using approach 1 and$73 141 million using approach 2. The economic burden of not providing surgical care to the standards of high-income countries was $95 004 million using approach 1 and$75 666 million using approach 2. The largest share of these costs resulted from premature death (97.7 per cent) and lack of access (97.0 per cent) in contrast to lack of quality. Conclusion For a comparatively non-complex emergency condition such as appendicitis, increasing access to care should be prioritized. Although improving quality of care should not be neglected, increasing provision of care at current standards could reduce societal costs substantially

Global economic burden of unmet surgical need for appendicitis

Background There is a substantial gap in provision of adequate surgical care in many low- and middle-income countries. This study aimed to identify the economic burden of unmet surgical need for the common condition of appendicitis. Methods Data on the incidence of appendicitis from 170 countries and two different approaches were used to estimate numbers of patients who do not receive surgery: as a fixed proportion of the total unmet surgical need per country (approach 1); and based on country income status (approach 2). Indirect costs with current levels of access and local quality, and those if quality were at the standards of high-income countries, were estimated. A human capital approach was applied, focusing on the economic burden resulting from premature death and absenteeism. Results Excess mortality was 4185 per 100 000 cases of appendicitis using approach 1 and 3448 per 100 000 using approach 2. The economic burden of continuing current levels of access and local quality was US $92 492 million using approach 1 and$73 141 million using approach 2. The economic burden of not providing surgical care to the standards of high-income countries was $95 004 million using approach 1 and$75 666 million using approach 2. The largest share of these costs resulted from premature death (97.7 per cent) and lack of access (97.0 per cent) in contrast to lack of quality. Conclusion For a comparatively non-complex emergency condition such as appendicitis, increasing access to care should be prioritized. Although improving quality of care should not be neglected, increasing provision of care at current standards could reduce societal costs substantially